LR769: Completed Phase III enrollment

LFB S.A., Les Ulis, France
Product: LR769
Business: Hematology
Molecular target: Factor

Read the full 125 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE